TRIB · NASDAQ
Trinity Biotech (TRIB) Stock Price & Fundamentals
Trinity Biotech (TRIB) closed at $486.01 on Oct 9, 2026, down 0.04% from the previous close of $486.20.
Share price, past year
1Y +25.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $486.01 |
| Sep 30, 2026 | $475.65 |
| Aug 31, 2026 | $487.51 |
| Jul 31, 2026 | $470.17 |
| Jun 30, 2026 | $446.41 |
| May 29, 2026 | $447.41 |
| Apr 30, 2026 | $431.27 |
| Mar 31, 2026 | $424.21 |
| Feb 27, 2026 | $423.11 |
| Jan 30, 2026 | $434.21 |
| Dec 31, 2025 | $425.25 |
| Nov 28, 2025 | $418.19 |
| Oct 31, 2025 | $400.26 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 374.2M
- Dividend yield
- —
- 52-week range
- $383.79 – $492.87
Market cap, P/E and dividend yield aren't shown for Trinity Biotech yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
Trinity Biotech reported revenue of $61.56M for fiscal 2024, up 8.31% from fiscal 2023.
Trinity Biotech reported a net loss of $31.79M in fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $61.56M | +8.3% | −$31.79M | −51.6% | — | −$4.60M |
| FY2023ended Dec 31, 2023 | $56.83M | −9.1% | −$24.02M | −42.3% | — | −$12.36M |
| FY2022ended Dec 31, 2022 | $62.52M | −23.0% | −$41.01M | −65.6% | — | −$2.02M |
| FY2021ended Dec 31, 2021 | $81.15M | −20.4% | $875.00K | 1.1% | — | $11.43M |
| FY2020ended Dec 31, 2020 | $101.98M | +12.8% | −$6.39M | −6.3% | — | $20.58M |
| FY2019ended Dec 31, 2019 | $90.44M | −6.8% | −$28.91M | −32.0% | — | $3.30M |
| FY2018ended Dec 31, 2018 | $97.04M | −2.1% | −$22.09M | −22.8% | — | −$299.00K |
| FY2017ended Dec 31, 2017 | $99.14M | −0.5% | −$40.27M | −40.6% | — | $4.41M |
| FY2016ended Dec 31, 2016 | $99.61M | −0.6% | −$100.63M | −101.0% | — | $6.01M |
| FY2015ended Dec 31, 2015 | $100.20M | — | $21.80M | 21.8% | — | $6.06M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2018ended Jun 30, 2018 | $25.00M | — | $6.70 |
| Q2 FY2017ended Jun 30, 2017 | $25.45M | — | $6.80 |
Company profile
- Name
- Trinity Biotech plc
- Ticker
- TRIB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Ida Business Park, Bray, Wicklow
- Incorporated in
- L2
- Fiscal year ends
- December
- SEC CIK
- 0000888721
Recent SEC filings
- Apr 30, 2026
- May 16, 2025
- Jul 12, 2024
- Apr 30, 2024
- May 16, 2023
- May 25, 2022
- May 2, 2022
- Apr 30, 2021
Frequently asked questions
What is Trinity Biotech's stock price?
Trinity Biotech (TRIB) closed at $486.01 on Oct 9, 2026, down 0.04% from the previous close of $486.20.
How much revenue does Trinity Biotech make?
Trinity Biotech reported revenue of $61.56M for fiscal 2024, up 8.31% from fiscal 2023.
Sources and methodology
Fundamentals come from Trinity Biotech plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures